secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2022-08-09T23:59:59+00:00
Accession:  0001297184-22-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar expands board to 10, appoints CFO Peters and EVP Liawatidewi as directors
--------------------------------------------------------------------------------

- Board size increased from 8 to 10, effective August 4, 2022.
- William J. Peters (CFO, EVP Finance, Treasurer) appointed as Class I director.
- Jacob Liawatidewi (EVP Corporate Administration & Sales/Marketing) appointed as Class I director.
- Diane G. Gerst deemed independent; now six of ten directors are independent.
- No changes to existing compensatory arrangements for the new directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718422000048/0001297184-22-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718422000048/amph-20220804x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-22-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer